Currently out of the existing stock ratings of Jonathan Lee, 48 are a BUY (85.71%), 8 are a HOLD (14.29%).

Jonathan Lee

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Lee, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 29.4% that have a potential upside of 19.42% achieved within 65 days.

Jonathan Lee’s has documented 104 price targets and ratings displayed on 8 stocks. The coverage is on Technology, Healthcare sectors.

Most recent stock forecast was given on ACN, Accenture plc.

Wall Street Analyst Jonathan Lee

Analyst best performing recommendations are on PTCT (PTC THERAPEUTICS).
The best stock recommendation documented was for ACN (ACCENTURE PLC) at 6/22/2026. The price target of $185 was fulfilled within 60 days with a profit of $61.65 (49.98%) receiving and performance score of 8.33.

Average potential price target upside

ACN Accenture plc CTSH Cognizant Technology Solutions Corp DAVA Endava Ltd EPAM EPAM Systems GLOB Globant SA KD Kyndryl Holdings PTCT PTC Therapeutics PRFT Perficient

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 20-Jun-2024

$210

$11.1 (5.58%)

$153

Buy Since 16-Nov-2021

$250

$51.1 (25.69%)

$180

Buy Since 09-Dec-2024

$260

$61.1 (30.72%)

$270

Buy Since 27-Sep-2018

$260

$61.1 (30.72%)

$380

Show more analysts

Please expand the browser size to see the chart

Which stock is Jonathan Lee most bullish on?

Potential upside of $31.71 has been obtained for EPAM (EPAM SYSTEMS)

Which stock is Jonathan Lee most reserved on?

Potential downside of -$0 has been obtained for DAVA (ENDAVA LTD)

What Year was the first public recommendation made by Jonathan Lee?

On 2022
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?